Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2018.0052
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Mary Ann Liebert Inc